Published in J Clin Pathol Suppl (Assoc Clin Pathol) on January 01, 1978
NPY receptors as potential targets for anti-obesity drug development. Br J Pharmacol (2011) 0.96
The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus. Regul Pept (2013) 0.84
The Beginnings of Pancreatology as a Field of Experimental and Clinical Medicine. Biomed Res Int (2015) 0.82
A novel peptide nanomedicine for treatment of pancreatogenic diabetes. Nanomedicine (2013) 0.78
Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus. PLoS One (2016) 0.75
Delta Cell Hyperplasia in Adult Goto-Kakizaki (GK/MolTac) Diabetic Rats. J Diabetes Res (2015) 0.75
Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia (1978) 5.21
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia (1976) 1.74
Bovine pancreatic peptide: action on gastric and pancreatic secretion in dogs. Am J Physiol (1977) 1.63
Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest (1978) 1.63
Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet (1976) 1.56
Candidate hormones of the gut. VI. Bovine pancreatic polypeptide (BPP) and avian pancreatic polypeptide (APP). Gastroenterology (1974) 1.54
A newly recognized pancreatic polypeptide; plasma levels in health and disease. Recent Prog Horm Res (1976) 1.45
Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet (1978) 1.39
Isolation and characterization of chicken insulin. Endocrinology (1968) 1.31
Pancreatic polypeptide and glucagon : non-random distribution in pancreatic islets. Life Sci (1976) 1.28
Gastric and cephalic stimulation of human pancreatic polypeptide release. Gastroenterology (1978) 1.16
Regulation in healthy subjects of the secretion of human pancreatic polypeptide, a newly recognized pancreatic islet polypeptide. Trans Assoc Am Physicians (1976) 1.15
Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas. Diabetologia (1978) 1.10
Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis. Experientia (1977) 1.10
Autoimmunity in diabetics induced by hormonal contaminants of insulin. Lancet (1979) 0.98
Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea. Gut (1979) 0.95
Pharmacokinetics of pancreatic polypeptide in man. Gut (1978) 0.91
The immunogenicity of insulin preparations. Acta Endocrinol Suppl (Copenh) (1976) 0.89
Localization of glucagonomas by catheterization of the pancreatic veins and with glucagon assay. Surg Gynecol Obstet (1977) 0.89
Inhibition of secretin stimulated pancreatic secretion by pancreatic polypeptide. Gut (1979) 0.83
Effect of bovine pancreatic polypeptide on basal pancreatic and biliary outputs in man. Dig Dis Sci (1979) 0.83
Is pancreatic polypeptide a marker for Zollinger-Ellison syndrome? Lancet (1978) 0.83
Identification of the D1-cell as the source of human pancreatic polypeptide (HPP). Gut (1976) 0.82
Effect of bovine pancreatic polypeptide on gastric acid and pepsin output in man. Acta Hepatogastroenterol (Stuttg) (1978) 0.80
Inhibitory effect of somatostatin on human pancreatic polypeptide secretion. Life Sci (1977) 0.79
Spectrum effects of a new polypeptide (third hormone?) isolated from the chicken pancreas. Gen Comp Endocrinol (1973) 0.79
Vagovagal stimulation of pancreatic-polypeptide secretion by graded distention of the gastric fundus and antrum in man. Digestion (1979) 0.78
Studies on the release of pancreatic polypeptide and its relationship to pancreatic exocrine function [proceedings]. J Endocrinol (1977) 0.78
Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology (2001) 3.38
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci (1995) 1.69
Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci (1995) 1.58
Effect of calcitonin on gastrointestinal regulatory peptides in man. Clin Endocrinol (Oxf) (1985) 1.42
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
Plasma motilin, gastrin, and enteroglucagon and feeding in the human newborn. Arch Dis Child (1980) 1.42
Dissociation of pepsinogen and acid secretion in the guinea pig. Gastroenterology (1988) 1.40
Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet (1978) 1.39
A white paper: the product of a pancreas cancer think tank. Cancer Res (2001) 1.39
Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression. Pancreas (2000) 1.33
Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology (1986) 1.32
Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide. Lancet (1983) 1.31
Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg (1993) 1.25
Regulatory peptides in the mammalian respiratory tract. Endocrinology (1982) 1.21
Effect of somatostatin infusion on intermediary metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia. Acta Paediatr Scand (1981) 1.20
Gut hormone release after intestinal resection. Gut (1982) 1.18
Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology (1985) 1.18
Radioimmunoassay of neuropeptide Y. Regul Pept (1984) 1.18
Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol (1997) 1.17
Peptidergic innervation of the human male genital tract. J Urol (1983) 1.16
Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut (1985) 1.15
Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon. Endocrinology (1991) 1.15
Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology (1983) 1.14
Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med (1994) 1.14
Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses. Gut (1985) 1.14
Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion (1984) 1.13
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun (1999) 1.12
Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides (1982) 1.11
On the role of the islets of Langerhans in pancreatic cancer. Histol Histopathol (2004) 1.10
Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas. Diabetologia (1978) 1.10
Somatostatin and the dumping syndrome. Br Med J (Clin Res Ed) (1985) 1.10
Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas. Histochemistry (1984) 1.07
Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas (1997) 1.06
Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, Frondoside A. Ann N Y Acad Sci (2008) 1.06
Pancreatic tumours produce neurotensin. J Clin Endocrinol Metab (1981) 1.05
Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res (2000) 1.05
Neuroendocrine responses to stimulation of the vagus nerves in bursts in conscious calves. J Physiol (1983) 1.04
In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets. J Surg Res (1998) 1.04
BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br J Cancer (2008) 1.03
Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer. Pancreatology (2001) 1.02
The distribution and origin of a novel brain peptide, neuropeptide Y, in the spinal cord of several mammals. J Comp Neurol (1984) 1.02
Effect of meal composition and sham feeding on duodenojejunal motility in humans. Dig Dis Sci (1992) 1.02
Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg (1996) 1.01
Adult cystic fibrosis: postprandial response of gut regulatory peptides. Gastroenterology (1983) 1.01
The intracellular mechanism of insulin resistance in pancreatic cancer patients. J Clin Endocrinol Metab (2000) 1.00
Effects of gastrointestinal hormones on fasting gallbladder storage patterns in man. Eur J Clin Invest (1979) 1.00
The effect of the mammalian neuropeptide, gastrin-releasing peptide (GRP), on gastrointestinal and pancreatic hormone secretion in man. Clin Sci (Lond) (1983) 1.00
Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. Surgery (1987) 0.99
Hormonal abnormalities of the pancreas and gut in cystic fibrosis. Gastroenterology (1980) 0.99
Transdifferentiation of human islet cells in a long-term culture. Pancreas (2001) 0.99
Autoimmunity in diabetics induced by hormonal contaminants of insulin. Lancet (1979) 0.98
Plasma enteroglucagon and CCK levels and cell proliferation in defunctioned small bowel in the rat. Dig Dis Sci (1984) 0.98
Proliferative effects of 'fibre' on the intestinal epithelium: relationship to gastrin, enteroglucagon and PYY. Gut (1987) 0.98
Comparison of effects of ingested medium- and long-chain triglyceride on gallbladder volume and release of cholecystokinin and other gut peptides. Dig Dis Sci (1987) 0.97
Gut hormones in acute diarrhoea. Gut (1983) 0.97
Positive correlation between symptoms and circulating motilin, pancreatic polypeptide and gastrin concentrations in functional bowel disorders. Gut (1985) 0.96
Pancreatic polypeptide from pancreatic endocrine tumours. Lancet (1980) 0.96
Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea. Gut (1979) 0.95
Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas). Br Med J (Clin Res Ed) (1981) 0.94
Elevated plasma peptide YY in human neonates and infants. Pediatr Res (1986) 0.94
A factor from pancreatic and colonic cancer cells stimulates glucose uptake and lactate production in myoblasts. Biochem Biophys Res Commun (1999) 0.94
Effect of gut regulatory peptides of intestinal luminal fluid in the rat. Life Sci (1981) 0.94
Maintenance of human islets in long-term culture. Differentiation (2000) 0.94
Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders. Am Surg (1996) 0.93
Neuropeptide Y (NPY) in the adrenal gland. J Auton Nerv Syst (1983) 0.93
Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction? Am J Surg (1989) 0.92
Distribution and postprandial release of porcine peptide YY. J Endocrinol (1987) 0.92
Neuropeptide Y in the human male genital tract. Life Sci (1984) 0.92
MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1. Biochem Biophys Res Commun (2001) 0.92
Plasma peptide YY (PYY) in dumping syndrome. Dig Dis Sci (1985) 0.92
Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas. Lancet (1983) 0.91
Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. Gastroenterology (1998) 0.91
Small intestinal growth caused by feeding red kidney bean phytohemagglutinin lectin to rats. Gastroenterology (1993) 0.91
Pharmacokinetics of pancreatic polypeptide in man. Gut (1978) 0.91
Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions. Br J Cancer (2001) 0.91
Factors affecting outcome following proximal and distal intestinal resection in the dog: an examination of the relative roles of mucosal adaptation, motility, luminal factors, and enteric peptides. Dig Dis Sci (1999) 0.91
Malignant diathesis from jejunal-ileal carcinoids. Am J Gastroenterol (1989) 0.90
Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells. Biochem Biophys Res Commun (1999) 0.90
Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse. Surgery (1998) 0.90
Pancreatic and gastrointestinal hormones in chronic pancreatitis. Digestion (1982) 0.90
Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. Clin Sci (Lond) (1981) 0.90
Release of motilin by oral and intravenous nutrients in man. Gut (1979) 0.90
Effect of graded exercise on esophageal motility and gastroesophageal reflux in trained athletes. Dig Dis Sci (1993) 0.89
Short-chain fatty acid release of peptide YY in the isolated rabbit distal colon. Scand J Gastroenterol (1991) 0.88
Feeding and the development of enteroinsular hormone secretion in the preterm infant: effects of continuous gastric infusions of human milk compared with intermittent boluses. Acta Paediatr Scand (1982) 0.88
Iatrogenic hyperinsulinism at birth. Lancet (1980) 0.88
Deoxycholate-stimulated release of peptide YY from the isolated perfused rabbit left colon. Am J Physiol (1989) 0.88